B. Riley reissued their buy rating on shares of Harrow Health (NASDAQ:HROW – Get Rating) in a research note published on Thursday, PriceTargets.com reports. B. Riley also issued estimates for Harrow Health’s FY2026 earnings at $4.27 EPS and FY2027 earnings at $6.22 EPS. A number of other analysts also recently issued reports on the stock. […]
B. Riley reaffirmed their buy rating on shares of Harrow Health (NASDAQ:HROW – Get Rating) in a research note published on Thursday morning, PriceTargets.com reports. B. Riley also issued estimates for Harrow Health’s FY2026 earnings at $4.27 EPS and FY2027 earnings at $6.22 EPS. HROW has been the subject of several other reports. Lake Street […]
SCYNEXIS (NASDAQ:SCYX – Get Rating) and Harrow Health (NASDAQ:HROW – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership. Profitability This table compares SCYNEXIS and Harrow Health’s net margins, […]
SCYNEXIS (NASDAQ:SCYX – Get Rating) and Harrow Health (NASDAQ:HROW – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations and risk. Insider & Institutional Ownership 49.9% of SCYNEXIS shares are owned […]
Harrow Health, Inc. (NASDAQ:HROW – Get Rating) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 2,210,000 shares, a growth of 6.8% from the March 31st total of 2,070,000 shares. Based on an average daily volume of 376,400 shares, the days-to-cover ratio is […]